MedPath
FDA Approval

Diphenoxylate Hydrochloride and Atropine Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 6, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Atropine(0.025 mg in 1 1)
Diphenoxylate(2.5 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

A-S Medication Solutions

A-S Medication Solutions

830016429

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diphenoxylate Hydrochloride and Atropine Sulfate

Product Details

NDC Product Code
50090-5592
Application Number
ANDA213413
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 25, 2020
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
AtropineActive
Code: 03J5ZE7KA5Class: ACTIBQuantity: 0.025 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
Code: W24OD7YW48Class: ACTIBQuantity: 2.5 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath